BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12/20/2012 9:45:22 AM
SAN RAFAEL, Calif., Dec. 21, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on December 18, 2012, the compensation committee of BioMarin's board of directors approved the grant to 14 employees of stock options to purchase 19,100 shares of common stock in the aggregate and 5,180 restricted stock units in the aggregate. The stock options and restricted stock units were granted pursuant to the BioMarin Pharmaceutical Inc. 2012 Inducement Plan, approved by the compensation committee of BioMarin's board of directors on May 8, 2012, and as inducements material to the new employees entering into employment with BioMarin in accordance with NASDAQ Listing Rule 5635(c)(4).
comments powered by